MINICK RUSSELL S 4

Accession 0001437749-21-004897

CIK 0001474735other

View on SEC.gov Company Profile

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 6:55 PM ET

Size

40.8 KB

Accession

0001437749-21-004897

Insider Transaction Report

Form 4

Period: 2021-03-01

GENERAC HOLDINGS INC.GNRC

MINICK RUSSELL S

Executive Vice President Sales

Transactions

Award
Common Stock
2021-03-01+5,368→ 13,136 total
Exercise/Conversion
Common Stock
2021-03-01$52.06/sh+5,788$301,352→ 20,980 total
Sale
Common Stock
2021-03-01$335.00/sh−5,740$1,922,900→ 15,240 total
Exercise/Conversion
Common Stock
2021-03-01$102.42/sh+2,360$241,699→ 17,552 total
Sale
Common Stock
2021-03-03$338.45/sh−894$302,576→ 14,298 total
Sale
Common Stock
2021-03-03$335.42/sh−3,820$1,281,295→ 9,117 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-03-01−6,239→ 0 total
Exercise: $40.12Exp: 2027-03-01→ Common Stock (6,239 underlying)
Award
Common Stock
2021-03-01+992→ 14,128 total
Sale
Common Stock
2021-03-01$335.00/sh−6,239$2,090,065→ 15,192 total
Sale
Common Stock
2021-03-01$335.00/sh−6,088$2,039,480→ 15,192 total
Sale
Common Stock
2021-03-03$337.10/sh−586$197,541→ 12,937 total
Tax Payment
Common Stock
2021-03-01$335.91/sh−1,913$642,596→ 12,215 total
Award
Common Stock
2021-03-01+2,977→ 15,192 total
Exercise/Conversion
Common Stock
2021-03-01$40.12/sh+6,239$250,309→ 21,431 total
Exercise/Conversion
Common Stock
2021-03-01$43.88/sh+6,088$267,141→ 21,280 total
Sale
Common Stock
2021-03-01$336.29/sh−48$16,142→ 15,192 total
Sale
Common Stock
2021-03-01$335.00/sh−2,360$790,600→ 15,192 total
Sale
Common Stock
2021-03-03$338.65/sh−775$262,457→ 13,523 total
Sale
Common Stock
2021-03-03$336.87/sh−1,548$521,476→ 7,569 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-03-01−6,088→ 6,088 total
Exercise: $43.88Exp: 2028-03-01→ Common Stock (6,088 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-03-01−5,788→ 11,576 total
Exercise: $52.06Exp: 2029-03-01→ Common Stock (5,788 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-03-01−2,360→ 7,081 total
Exercise: $102.42Exp: 2030-03-01→ Common Stock (2,360 underlying)
Award
Stock Option (Right to Buy)
2021-03-01+2,718→ 2,718 total
Exercise: $335.91Exp: 2031-03-01→ Common Stock (2,718 underlying)

Footnotes (9)

[F1]Subject to continued service through the vesting date, the Restricted Shares shall all vest in equal installments on each of the first three (3) anniversaries of the Date of Grant.
[F2]Subject to continued service through the vesting date, the Restricted Shares shall vest in full on the third anniversary of the Date of Grant.
[F3]The shares were sold pursuant to the terms of a trading plan under Rule 10b5-1 previously entered into on February 25, 2021.
[F4]The price reported is the weighted average price. The shares were sold pursuant to the terms of a trading plan under Rule 10b5-1 previously entered into on February 25, 2021. The shares were sold in multiple transactions at prices ranging from $338.39 to $338.64, inclusive. The reporting person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares and the prices at which the shares were sold.
[F5]The price reported is the weighted average price. The shares were sold pursuant to the terms of a trading plan under Rule 10b5-1 previously entered into on February 25, 2021. The shares were sold in multiple transactions at prices ranging from $338.48 to $339.22, inclusive. The reporting person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares and the prices at which the shares were sold.
[F6]The price reported is the weighted average price. The shares were sold pursuant to the terms of a trading plan under Rule 10b5-1 previously entered into on February 25, 2021. The shares were sold in multiple transactions at prices ranging from $335.23 to $335.98, inclusive. The reporting person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares and the prices at which the shares were sold.
[F7]The price reported is the weighted average price. The shares were sold pursuant to the terms of a trading plan under Rule 10b5-1 previously entered into on February 25, 2021. The shares were sold in multiple transactions at prices ranging from $336.44 to $337.17, inclusive. The reporting person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares and the prices at which the shares were sold.
[F8]Subject to continued service through the vesting date, the Options shall all vest in equal installments on each of the first four (4) anniversaries of the Date of Grant.
[F9]Subject to continued service through the vesting date, the Options vested in equal installments on each of the first four (4) anniversaries of the Date of Grant.

Documents

1 file

4
rdgdoc.xmlPrimary
FORM 4

Issuer

GENERAC HOLDINGS INC.

CIK 0001474735

→

Entity typeother

Related Parties

filerCIK 0001302363

Filing Metadata

Form type: 4
Filed: Mar 2, 7:00 PM ET
Accepted: Mar 3, 6:55 PM ET
Size: 40.8 KB

View on SEC.gov